Related Experiment Video
Updated: Feb 26, 2026

05:39
A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
Published on: June 13, 2025
966
Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.
Eileen E Moran1, Cuiling Wang2, Mindy Katz3
1Department of Psychology, Fordham University, Bronx, NY, USA.
Neurobiology of Aging
|July 22, 2017
Summary
Carrying a glucocerebrosidase (GBA) gene mutation is linked to Parkinson's disease. This study found GBA mutation carriers experienced faster verbal memory decline, but no motor changes, in older adults.
Area of Science:
- Neuroscience
- Genetics
- Gerontology
Background:
- Glucocerebrosidase (GBA) gene mutations are a known risk factor for Parkinson's disease and dementia with Lewy bodies.
- The penetrance of GBA mutations for these neurodegenerative diseases is low in heterozygous carriers.
- Understanding the impact of GBA mutations on cognitive and motor function in aging populations is crucial.
Purpose of the Study:
- To investigate the relationship between heterozygous GBA mutation status and cognitive and motor functioning in non-demented, non-Parkinsonian community-dwelling older adults.
- To assess the longitudinal effects of GBA mutations on specific cognitive domains and motor performance.
- To determine the extent of cognitive and motor decline associated with carrying a single GBA mutation.
Main Methods:
- Longitudinal study of 736 community-dwelling older adults (age ≥70 years) over an average of 6 years.
- Analysis of 28 participants with a single GBA mutation (primarily N370S) compared to non-carriers.
- Linear mixed effects models used to assess the effect of mutation status on cognitive and motor function, including verbal memory (Free and Cued Selective Reminding Test).
Main Results:
- Heterozygous GBA mutation carriers exhibited a significantly greater decline in verbal memory over time (p < 0.05).
- No significant differences were observed in motor function between carriers and non-carriers.
- No differences were found in other cognitive domains assessed.
Conclusions:
- Harboring a single GBA mutation is associated with an accelerated decline in verbal memory in aging individuals.
- The overall burden of a single GBA mutation on cognitive and motor function appears limited in this cohort.
- Further research is warranted to fully elucidate the long-term neurological implications of GBA mutations in aging populations.
Related Concept Videos
Cognitive Development During Adulthood
973
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
973
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
267
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
267

